Pharmact

The project represents a legitimate MedTech company (Pharmact GmbH) with established products (BELTEST-IT, SARS-CoV-2 tests) and a verifiable history since 2014. However, the submission itself is of critically low quality, containing false or exaggerated claims (e.g., 'most people have used my product', 'audience reach: everyone') and nonsensical financial data ('marketcap 50000'). While the underlying technology has high real-world utility, the submission fails to provide credible evidence of traction, resulting in a low Proof of Usefulness score primarily due to data unreliability and red flags.